Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Slovenia
  4. Ljubljana Stock Exchange
  5. Krka, d. d.
  6. Summary
    KRKG   SI0031102120

KRKA, D. D.

(KRKG)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Ljubljana Stock Exchange
06/16/2021 06/17/2021 06/18/2021 06/21/2021 06/22/2021 Date
105.5 104.5 104 104.5 100.5 Last
3541 9912 3865 5195 18571 Volume
0.00% -0.95% -0.48% +0.48% -3.83% Change
Estimated financial data (e)
Sales 2021 1 568 M 1 870 M 1 870 M
Net income 2021 239 M 285 M 285 M
Net cash position 2021 336 M 401 M 401 M
P/E ratio 2021 -
Yield 2021 5,00%
Sales 2022 1 619 M 1 931 M 1 931 M
Net income 2022 277 M 330 M 330 M
Net cash position 2022 436 M 520 M 520 M
P/E ratio 2022 10,1x
Yield 2022 4,92%
Capitalization 3 138 M 3 736 M 3 742 M
EV / Sales 2021 1,79x
EV / Sales 2022 1,67x
Nbr of Employees 11 639
Free-Float 68,0%
More Financials
Company
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and... 
Sector
Pharmaceuticals
Calendar
07/08 | 07:00amShareholder meeting
More about the company
Ratings of Krka, d. d.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about KRKA, D. D.
06/02KRKA D Dá : Employees are Krka's main competitive advantage
PU
05/20KRKA D Dá : Report First Quarter 2021 Business Results
PU
04/08KRKA D Dá : Proposed dividend for Krka shareholders 17.6% higher than last year
PU
2020KRKA D Dá : Reports Business Results for the First Nine Months Ended 30 Septembe..
PU
2020KRKA, D. D. : Ex-dividend day for final dividend
FA
2020KRKA D Dá : Reports First Quarter 2020 Business Results
PU
2020KRKA D Dá : Proposed dividend for Krka shareholders 32.8% higher than last year
PU
2020KRKA D Dá : Presents the 2019 Unaudited Performance Results
PU
2020KRKA D D NOVO MESTOá : Estimation of Krka Business Performance in 2019
PU
2019KRKA D D NOVO MESTOá : receives two prestigious awards by the Ljubljana Stock Ex..
PU
2019KRKA D D NOVO MESTOá : Presents January–September 2019 Operating Results
PU
2019KRKA D D NOVO MESTOá : World Mental Health Day
PU
2019KRKA D D NOVO MESTOá : new Development-Control Centre 4 expands the company's ca..
PU
2019KRKA D D NOVO MESTOá : Striving for greater mobility worldwide
PU
2019KRKA D D NOVO MESTOá : Life is a collage of precious memories, but is that true ..
PU
More news
News in other languages on KRKA, D. D.
2014Bruxelles inflige une amende à six laboratoires pharmaceutiques
More news
Chart KRKA, D. D.
Duration : Period :
Krka, d. d. Technical Analysis Chart | KRKG | SI0031102120 | MarketScreener
Technical analysis trends KRKA, D. D.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 100,50 €
Average target price 92,75 €
Spread / Average Target -7,71%
EPS Revisions
Managers and Directors
NameTitle
Jo×e Colaric Chairman-Management Board & CEO
Brane Kastelec Finance Director
Jo×e Mermal Chairman-Supervisory Board
Vinko Zupancic Director-API Research & Development
AleÜ Rotar Director-Pharmaceutical R&D, Production
Sector and Competitors